Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.059 | 0.7 |